Intradermal mesotherapy versus intravenous dexketoprofen for the treatment of migraine headache without aura: a randomized controlled trial.

ABSTRACT:

Background

Migraine is a prevalent disabling primary headache disorder that is classified into two major types: migraine without aura and migraine with aura. New therapeutic methods to reduce migraine headaches in the emergency department (ED) include intradermal mesotherapy.

Objective

Compare the efficacy of intradermal mesotherapy versus a systemic therapy in pain control in patients with headache related to migraine without aura.

Design

Prospective parallel-group randomized controlled trial.

Setting

University hospital in Turkey.

Patients and methods

Patients 18 years of age and older who were admitted to the ED over a 15-month period with headache related to migraine without aura were eligible for inclusion if they had a VAS score of 4 or above. Pati

SUBMITTER: Akbas I 

PROVIDER: S-EPMC8176379 | biostudies-literature | 2021 May-Jun

REPOSITORIES: biostudies-literature